Publicaciones (46) Publicaciones en las que ha participado algún/a investigador/a

2014

  1. A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer

    Human Genetics, Vol. 133, Núm. 5, pp. 525-534

  2. A simple and portable device for the quantification of TNF-α in human plasma by means of on-chip magnetic bead-based proximity ligation assay

    Biosensors and Bioelectronics, Vol. 54, pp. 499-505

  3. Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: Results from a multi-centric study

    PLoS ONE, Vol. 9, Núm. 1

  4. Características fenotípicas de los pacientes con síndrome de poliposis serrada de colon: Estudio de 23 casos

    Cirugia Espanola, Vol. 92, Núm. 10, pp. 659-664

  5. Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening

    Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 9, pp. 1884-1892

  6. Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions

    European Journal of Gastroenterology and Hepatology, Vol. 26, Núm. 12, pp. 1380-1384

  7. Clinical relevance of KRAS mutations in codon 13: Where are we?

    Cancer Letters

  8. Correction: Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: Results from a multi-centric study (PLoS ONE)

    PLoS ONE

  9. Corrigendum to Clinical relevance of KRAS mutations in codon 13: Where are we? [Cancer Lett. 343 (1 (2013) 1-5]

    Cancer Letters

  10. Current approaches for predicting a lack of response to Anti-EGFR therapy in KRAS wild-type patients

    BioMed Research International, Vol. 2014

  11. Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening

    United European Gastroenterology Journal, Vol. 2, Núm. 6, pp. 522-529

  12. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: Comparison with NICE and SIGN referral criteria

    Colorectal Disease, Vol. 16, Núm. 8

  13. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells

    Cell Death and Disease, Vol. 5, Núm. 3

  14. Disease severity in familial cases of IBD

    Journal of Crohn's and Colitis, Vol. 8, Núm. 3, pp. 234-239

  15. Effect of oral anticoagulants on the outcome of faecal immunochemical test

    British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337

  16. Effects of resveratrol and other polyphenols in hepatic steatosis

    World Journal of Gastroenterology, Vol. 20, Núm. 23, pp. 7366-7380

  17. Embryonic stem cell factors and pancreatic cancer

    World Journal of Gastroenterology, Vol. 20, Núm. 9, pp. 2247-2254

  18. Endoscopic submucosal dissection

    Endoscopy, Vol. 46, Núm. 4, pp. 361-370

  19. Erratum: Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells (Cell Death and Disease (2014) 5 (e1142) DOI: 10.1038/cddis.2014.102)

    Cell Death and Disease

  20. Erratum: Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer (Genetics in Medicine (2014) DOI: 10.1038/gim.2014.89)

    Genetics in Medicine